How to Use Selank: Administration, Reconstitution & Storage (2026)

From Peptidepedia, the trusted peptide wiki.

Administration

Selank is primarily administered intranasally, which distinguishes it from most peptides in the biohacking space that require subcutaneous injection. The intranasal route is not merely a convenience. It is pharmacologically optimal for Selank. Like Semax, Selank's small molecular size (seven amino acids) and rapid absorption kinetics allow efficient uptake across the nasal mucosa before the cavity's mucociliary clearance mechanism removes the compound — a window that larger, slower-absorbing peptides typically miss.

Intranasal Delivery (Preferred Route)

Intranasal administration exploits the olfactory and trigeminal nerve pathways to deliver Selank directly to the central nervous system, bypassing the blood-brain barrier. Pharmacokinetic studies in rats demonstrated that Selank is detectable in plasma within 30 seconds and in brain tissue within 2 minutes of intranasal administration. This rapid CNS delivery accounts for the onset of anxiolytic effects within minutes of dosing.

The Russian-approved formulation is a 0.15% solution in a metered-dose nasal spray device. Each spray delivers a calibrated dose, eliminating the need for reconstitution, sterile technique, or syringes. For users outside Russia, compounding pharmacies and research suppliers offer Selank in both pre-made nasal spray and lyophilized powder formats.

Intranasal technique:

Clear nasal passages before administration
Tilt head slightly forward
Insert spray nozzle into nostril, angling slightly away from the nasal septum
Administer one to two sprays per nostril
Breathe gently through the nose for 10 to 15 seconds after application
Avoid blowing the nose for several minutes post-administration

Subcutaneous Injection (Alternative)

When nasal spray formulations are unavailable, Selank can be administered subcutaneously. This route requires reconstitution of lyophilized powder with bacteriostatic water.

Reconstitution for subcutaneous use:

Use a 1:1 ratio (e.g., 5 mg Selank + 5 mL bacteriostatic water = 1 mg/mL)
Add water slowly along the vial wall; do not inject directly onto the powder
Swirl gently until dissolved; do not shake
Refrigerate reconstituted solution and use within 28 days

Subcutaneous bioavailability is adequate but lacks the rapid CNS delivery advantage of the intranasal route. Onset of effects is slower (15 to 30 minutes versus 2 to 5 minutes for intranasal).

Reconstitution, Storage and Prep

Pre-Made Nasal Spray (No Reconstitution Required): If obtained as a pre-made nasal spray solution (as marketed in Russia), no preparation is needed. Store at 2 to 8 degrees Celsius (refrigerator) and use within the timeframe specified by the manufacturer (typically 30 days after opening).

Lyophilized Powder (Requires Reconstitution):

Allow the vial to reach room temperature
Use bacteriostatic water (0.9% benzyl alcohol) as the reconstitution vehicle
Draw the appropriate volume into an insulin syringe
Insert the needle and inject water slowly along the interior vial wall
Swirl gently until fully dissolved; do not shake
Solution should be clear and colorless

Common Reconstitution Ratio:

5 mg Selank + 5 mL bacteriostatic water = 1 mg/mL
For nasal spray: transfer reconstituted solution to a sterile metered-dose nasal spray bottle

Storage Guidelines:

Lyophilized powder: Store at -20 degrees Celsius for long-term; stable at 2 to 8 degrees Celsius for several months
Protect from light and moisture
Reconstituted solution: Store at 2 to 8 degrees Celsius; use within 28 days
Discard if solution becomes cloudy, discolored, or contains particles

Frequently Asked Questions

Both are Russian-developed intranasal peptides, but they target different systems. Selank is derived from tuftsin and primarily modulates GABAergic and serotonergic pathways for anxiolytic effects. Semax is an ACTH(4-7) analog that primarily enhances dopaminergic signaling and BDNF expression for cognitive stimulation. Selank is the stabilizer; Semax is the accelerator.

The most common intranasal protocol is 200 to 400 mcg administered two to three times daily. Russian clinical studies used 250 to 300 mcg intranasal doses in 14-day courses. Daily doses up to 1,000 mcg have been used without reported adverse effects, though doses above 300 mcg are typically split across multiple administrations.

Selank has a notably clean side effect profile. The most commonly reported effects are mild nasal irritation, transient stinging, or dryness at the administration site. Unlike benzodiazepines, Selank does not cause sedation, cognitive impairment, tolerance, or dependence in published clinical data.

Selank is not FDA-approved for any indication in the United States. It exists in a regulatory gray area as a research compound. In September 2024, Selank acetate was removed from the FDA's Category 2 bulk drug substances list following nomination withdrawal, and its status for compounding use remains under review.

Selank nasal spray (0.15% solution in Russia) is administered as one to two drops per nostril, two to three times daily. Each administration delivers approximately 200 to 300 mcg. The spray does not require reconstitution. Treatment courses typically last 14 days, with a one-month rest period between cycles.

This content is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.